Back to Search Start Over

Genetic epistasis regulates amyloid deposition in resilient aging.

Authors :
Felsky D
Xu J
Chibnik LB
Schneider JA
Knight J
Kennedy JL
Bennett DA
De Jager PL
Voineskos AN
Source :
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2017 Oct; Vol. 13 (10), pp. 1107-1116. Date of Electronic Publication: 2017 Mar 17.
Publication Year :
2017

Abstract

Introduction: The brain-derived neurotrophic factor (BDNF) interacts with important genetic Alzheimer's disease (AD) risk factors. Specifically, variants within the SORL1 gene determine BDNF's ability to reduce amyloid β (Aβ) in vitro. We sought to test whether functional BDNF variation interacts with SORL1 genotypes to influence expression and downstream AD-related processes in humans.<br />Methods: We analyzed postmortem brain RNA sequencing and neuropathological data for 441 subjects from the Religious Orders Study/Memory and Aging Project and molecular and structural neuroimaging data for 1285 subjects from the Alzheimer's Disease Neuroimaging Initiative.<br />Results: We found one SORL1 RNA transcript strongly regulated by SORL1-BDNF interactions in elderly without pathological AD and showing stronger associations with diffuse than neuritic Aβ plaques. The same SORL1-BDNF interactions also significantly influenced Aβ load as measured with [ <superscript>18</superscript> F]Florbetapir positron emission tomography.<br />Discussion: Our results bridge the gap between risk and resilience factors for AD, demonstrating interdependent roles of established SORL1 and BDNF functional genotypes.<br /> (Copyright © 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1552-5279
Volume :
13
Issue :
10
Database :
MEDLINE
Journal :
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publication Type :
Academic Journal
Accession number :
28322202
Full Text :
https://doi.org/10.1016/j.jalz.2017.01.027